BusinessKERX DEADLINE: Hagens Berman Reminds Investors in Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) of October 3, 2016 Lead Plaintiff Deadline and of Expanded Securities Case Class PeriodBy Nasdaq OMXSep 8, 2016, 1:30 PM UTC
